About FDA
- Mandate
- Mission
- Vision
- Function
- Goals
- FDA Quality Policy
- FDA Core Values
- Organization Structure
- FDA Management Team
- FDA Inspectorate Team
As a regulatory agency under the Department of Health, the Food and Drug Administration, created under Republic Act No. 3720, series of 1963, as amended by Executive Order 175, series of 1987, otherwise known as the “Food, Drugs and Devices, and Cosmetics Act”, and subsequently Republic Act No. 9711 otherwise known as “The Food and Drug Administration Act of 2009”, is mandated to ensure the safety, efficacy or quality of health products which include food, drugs, cosmetics, devices, biologicals, vaccines, in-vitro diagnostic reagents, radiation-emitting devices or equipment, and household/urban hazardous substances, including pesticides and toys, or consumer products that may have an effect on health which require regulations as determined by the FDA.
Among others, the FDA is also mandated to enforce theprovisions of the following laws:
- RA9502, or The Universally Accessible Cheaper and QualityMedicine Act of2008
- RA 6675, orThe Generics Act Of 1988,
- RA 10918, or The Pharmacy Law,
- RA 9211, or The Tobacco Regulation Act of 2003
- RA 7394, or The Consumer Act of the Philippines
- RA 7581/10623, or The Price Act
- RA 10611, or The Food Safety Act of 2013
- RA 8172, or The ASIN Law,
- RA 8203, or The Special Law on Counterfeit Drug
- RA 8976, or The Food Fortification Law
- RA 9165, or The Comprehensive Dangerous Drugs Act
- RA 9257, or The Expanded Senior Citizens Act of 2003
- PD No. 881, or The Household Hazardous Act
- EO No. 51, or The Milk Code of the Philippines
- RA 10354, or The Responsible Parenthood and Reproductive HealthBill of 2012
- PD 856, or The Code of Sanitation of the Philippines
To guarantee the safety, quality, purity, efficacy of products in order to protect and promote the right to health of the general public.
The Food and Drug Administration to be an internationally recognized center of excellence in health product regulation by 2026.
In order to protect and promote the right to health of the Filipino people and to establish and maintain an effective health products regulatory system responsive to the country’s health needs and problems, the FDA shall perform the following functions as provided by existing laws:
- To establish safety or efficacy standards and quality measures for foods, drugs and devices and cosmetics and other health product;
- To undertake appropriate health manpower development and research, responsive to the country’s health needs and problems;
- To assume primary jurisdiction in the collection of samples of health products;
- To analyze and inspect health products;
- To establish analytical data to serve as basis for the preparation of health products standards, and to recommend standards of identity, purity, safety, efficacy, quality and fill of container;
- To issue certificates of compliance with technical requirements to serve as basis for the issuance of appropriate authorization and spot-check for compliance with regulations regarding operation of manufacturers, importers, exporters, distributors, wholesalers, drug outlets, and other establishments and facilities of health products, as determined by the FDA;
- To conduct appropriate tests on all applicable health products prior to the issuance of appropriate authorizations to ensure safety, efficacy, purity, and quality;
- To require all manufacturers, traders, distributors, importers, exporters, wholesalers, retailers, consumers, and non-consumer users of health products to report to the FDA any incident that reasonably indicates that said product has caused or contributed to the death, serious illness or serious injury to a consumer, a patient, or any person;
- To issue cease and desist orders motu propio or upon verified complaint for health produts, whether or not registered with the FDA Provided, That for registered health products, the cease and desist order is valid for thirty (30) days and may be extended for sixty (60) days only after due process has been observed;
- To order the ban, recall, and/or withdrawal of any health product, after due process, found to have caused the death, serious illness or serious injury to a consumer or patient, or is found to be imminently injurious, unsafe, dangerous, or grossly deceptive, and to require all concerned to implement the risk management plan which is a requirement for the issuance of the appropriate authorization;
- To strengthen the post market surveillance system in monitoring health products as defined in this Act and incidents of adverse events involving such products;
- To develop and issue standards and appropriate authorizations that would cover establishments, facilities and health products;
- To conduct, supervise, monitor and audit research studies on health and safety issues of health products undertaken by entities duly approved by the FDA;
- To prescribe standards, guidelines, and regulations with respect to information, advertisements and other marketing instruments and promotion, sponsorship, and other marketing activities about the health products;
- To maintain bonded warehouses and/or establish the same, whenever necessary or appropriate, as determined by the director-general for confiscated goods in strategic areas of the country especially at major ports of entry; and
- To exercise such other powers and perform such other functions as may be necessary to carry out its duties and responsibilities.
- To protect and promote the right to health of the Filipino people by ensuring the safety, efficacy, quality, and purity of foods, drugs, devices, and cosmetics, and
- To establish and maintain an effective health products regulatory system responsive to the country’s health needs and problems.
Ensure the safety, efficacy, quality and purity of health products by fostering integrity, transparency and excellence; developing and maintaining evidence-based standards and policies, in a healthy and safe work environment.
Bawat Kawani ng FDA, Lingkod Bayani"
EXCELLENCE - Pagiging Mahusay refers to our Highest degree of professionalism and superior work standard in discharging one's duty
LEADERSHIP - Mahusay na Pamumuno refers to the management thinking that all employees in all levels of public service who, at their best, care and do something about the challenges faced by theFDA
INTEGRITY - Pagiging Matapat refers to our consistent adherence to strong and ethical principles, wether alone or in public
PATRIOTISM - Pagiging Makabayan refers to our love for our country and fellowmen
SPIRITUALITY - Pagiging Maka-Diyos refers to our belief, love and faith for a Higher Being
![]() | Dr. Oscar G. Gutierrez, Jr., MPA, PCVPH Officer-In-Charge-Director General | Office of the Director General |
|
![]() | Atty. Ronald R. De Veyra, MBA, CESO IIDeputy Director General for Internal Management | Office of the Deputy Director General for Internal Management |
|
![]() | Arnold G. Alindada, Dr. HCM, MPH, RMT Director II Officer-In-Charge Deputy Director General for Field Regulatory Operations Office | Office of the Deputy Director General for Field Regulatory Operations Office |
|
![]() | Engr. Ana Trinidad F. RiveraDirector IV | Center for Cosmetics and Household Urban Hazardous Substances Regulation and Research |
|
![]() | Jesusa Joyce N. CirunayDirector IV | Center for Drug Regulation and Research |
|
![]() | Engr. Ma. Cecilia C. MatienzoDirector IV | Center for Device Regulation, Radiation and Health Research |
|
![]() | Pilar Marilyn M. PagayunanDirector IV | Center for Food Regulation and Research |
|
![]() | Jocelyn E. Balderrama, RPh., MBADirector III | Common Services Laboratory |
|
![]() | Atty. Emilio L. Polig, Jr.Director III | Legal Services Support Center |
|
![]() | Estrellita B. Pastolero, MGMOfficer-In-Charge | Food and Drug Action Center |
|
![]() | Irene Florentino-Fariñas, RPh., MD, MNSADirector II, Officer-In-Charge | Policy and Planning Service |
|
![]() | Gomel C. Gabuna, LlB, MDM, CESEDirector II | North Luzon Cluster, Field Regulatory Operations Officer |
|
![]() | Carolyn P. CustodioDirector II, Officer-In-Charge | South Luzon Cluster, Field Regulatory Operations Office |
|
![]() | Rica Reina C. AumentadoDirector II, Officer-In-Charge | Visayas Cluster, Field Regulatory Operations Office |
|
![]() | Deborah S. LegaspiDirector II | Mindanao East Cluster, Field Regulatory Operations Office |
|
![]() | Sharon Rose P. GarciaDirector II, Officer-In-Charge | Mindanao West Cluster, Field Regulatory Operations Office |
|
DRUGS GDP and GMP INSPECTORS |
RFO CAR |
GMP | GDP |
Nadia D. Navarro, FDRO II ** | Nadia D. Navarro, FDRO II |
Rochelle T. Bayanes, FDRO II | |
Giovanni G. Monang, FDRO II |
RFO 1
GMP | GDP |
Jeffrey J. Gamboa, FDRO II ** | Veronica F. Obille, FDRO III/Regional Supervisor |
Airene Z. Barlin, FDRO II | |
Jeffrey J. Gamboa, FDRO II | |
Imelda B. Calmada, FDRO II |
RFO 2
GMP | GDP |
Janelle L. Lim, FDRO II ** | Alegria G. Ong, FDRO III & RFO II Supervisor |
Shanida Joy O. Singson, FDRO II ** | Janelle L. Lim, FDRO II |
Shanida Joy O. Singson, FDRO II | |
Consuelo R. Ricablanca, FDRO II | |
Dianne Cristelle S. Maningas, FDRO II | |
Krisha Melody G. Lavadia, FDRO II | |
Rose Agatha D. Pagalilauan, LO III |
RFO 3
GMP | GDP |
Clarissa A. Mendoza, FDRO III * | Virginia P. Timbol, FDRO IV & RFO III Supervisor |
Gia Heida N. Bognot, FDRO II ** | Alona O. Palmares, FDRO III |
Clarissa A. Mendoza, FDRO III | |
Gia Heida N. Bognot, FDRO II | |
Ma. Concepcion P. Canilao, FDRO II | |
Benedict R. Balajadia, FDRO II | |
Imee S. Patriarca, FDRO II | |
Ronald D. Tiglao, FDRO II | |
Kristie Ann T. Abuel, FDRO II | |
Diana Mae C. Castro, FDRO I | |
Krinessa S. Manlapat, FDRO II |
RFO NCR
GMP | GDP |
Ma. Lynn Rachelle A. Natividad, FDRO III * | Fleurdelis E. Mendiola, Pharmacist IV |
Rioriza A. Ortilano, FDRO III * | Archie M. Balilo, FDRO II |
Ma. Lolita B. Abo-ol, FDRO III * | Gian Angelo L. Cruz, FDRO II |
Marissa C. Fajardo, FDRO III * | Theresa A. Dizon, FDRO II |
Don Bryan A. Orendain, FDRO III * | Cristal Jule B. Dolendo, FDRO II |
Ma. Suzette R. Sta. Clara, FDRO III * | Maureen D. Mabulay, FDRO II |
Angeli B. Casala, FDRO III * | Gladys Jane M. Martinez, FDRO II |
Frances Glorie D. De Luna, FDRO III * | Mark Anthony A. Polpol, FDRO II |
Mary Angeline V. Francisco, FDRO II * | Sarah Y. Manucdoc, FDRO I |
Michael E. Galang, FDRO II * | Clare Louise Reyes, FDRO I |
Lelian B. Indac, FDRO II * | |
Jackerwin R. Maur, FDRO II * | |
Cristy Hanna V. Mendoza, FDRO II * | |
Rowena K. Velasco, FDRO II * | |
Irene A. Dimayacyac, FDRO II * |
RFO 4A
GMP | GDP |
Cristian V. Martinez, FDRO II | |
Richard P. Gerinas, FDRO II |
RFO 4B
GMP | GDP |
Ephraim Joseph D. Dela Cruz, FDRO II ** | Luzvimin G. Atienza, FDRO III |
Lilibeth D. Mayor, FDRO II | |
Ephraim Joseph D. Dela Cruz, FDRO II |
RFO 5
GMP | Drug GDP |
Edwin E. Castillo, Jr., FDRO II ** | Emily M. Espinas, FDRO III |
Rica D. Morales, FDRO II ** | Silvia C. Lopez, FDRO II |
Ma. Dolores V. Alegre, FDRO II | |
Edwin E. Castillo, Jr., FDRO II | |
Elias J. Almajeda, FDRO II | |
Ma. Jehan A. Icamen, FDRO II | |
Rica D. Morales, FDRO II | |
Rachelle Flor Faustino-Agsolid, FDRO II | |
Hazel Ann A. Alagaban, FDRO I |
RFO 6
GMP | Drug GDP |
Mary Jade S. Tan, FDRO II | |
Ma. Gina G. Joquico, FDRO II | |
Maricon G. Dimatulac, FDRO II | |
Mabel U. Concepcion, FDRO II | |
Gladys Mae V. Sanchez, FDRO II | |
Arlene G. Punsalan, FDRO II | |
Gemma T. Tabiano, FDRO II |
RFO 7
GMP | Drug GDP |
Ma. Salome R. Largo, FDRO II ** | Sarah C. Oriol, FDRO III |
Irish B. Samar, FDRO I ** | Therese Antoniette V. Cuyos, FDRO II |
Ma. Salome R. Largo, FDRO II | |
Christa Marie L. Baritua, FDRO II | |
Lucrecia O. Matugas, FDRO II | |
Vicky R. Sibala, FDRO II | |
Diana A. Tindoy, FDRO I | |
Krissa Joy E. Elardo, FDRO I | |
Irish B. Samar, FDRO I |
RFO 8
GMP | GDP |
Benczint Benedikt C. Ortega, FDRO III ** | Benczint Benedikt C. Ortega, FDRO III |
Ma. Christine T. Ty, FDRO II | |
Pinky A. Bantanos, FDRO II | |
Khin Janique M. Lagonoy, FDRO I | |
Laura Marie C. Carcueva, FDRO II | |
Sheryl Mae C. Gente, FDRO II | |
Emelyn O. Mercado, FDRO II | |
Ma. Cielo R. Yee, FDRO II |
RFO 9
GMP | Drug GDP |
Gladys Valerie Kaye R. Angeles, FDRO II ** | Kathrina U. Hassan, FDRO III |
Gladys Valerie Kaye R. Angeles, FDRO II |
RFO 10
GMP | Drug GDP |
Lorelie Joy A. Acha, FDRO II ** | Lorelie Joy A. Acha, FDRO II |
Anthonette K. Melgo, FDRO II | |
Desie A. Maghamil, FDRO II | |
Ma. Auralynn V. Macalisang, FDRO II |
RFO 11
GMP | Drug GDP |
Eba Marie Antonette W. Inis, FDRO IV & RFO XI Regional Supervisor ** | Phyllis Irene Pineda – FDRO III |
Jan Paul S. Cano, FDRO II ** | Araceli V. Arceo, FDRO II |
RFO 12
GMP | GDP |
Mayen P. Abdullah, FDRO II ** | Nicanora D. Rabara, FDRO III & RFO XII Regional Supervisor |
Reshyl Jean T. Morano, LO III ** | Mayen P. Abdullah, FDRO II |
John David O. Garduque, FDRO II | |
Maria Celestina B. Pascual, FDRO II | |
Jeselle L. Mationg, FDRO II |
RFO 13
GMP | GDP |
Keith Bryan Vincent R. Angeles, FDRO II ** | Perla B. Alvizo, FDRO III/ Regional Supevisor |
Lucille Glenda T. Bug-os, FDRO II ** | Keith Bryan Vincent R. Angeles, FDRO II |
Lucille Glenda T. Bug-os, FDRO II | |
Virginia K. Delani, FDRO II | |
Richel B. Prado, FDRO II | |
Potenciana A. Santiago, FDRO II |
* - Full time GMP Inspector
** - Part time GMP Inspector
FAQs
Why the FDA is important? ›
The FDA is responsible for protecting and promoting public health through regulation and supervision of food safety, dietary supplements, tobacco products, over-the-counter and prescription animal and human medications, vaccines, medical devices, etc.
Listen to pronunciation. (... ad-MIH-nih-STRAY-shun) An agency in the U.S. federal government whose mission is to protect public health by making sure that food, cosmetics, and nutritional supplements are safe to use and truthfully labeled.
What are the 5 phases of FDA approval? ›- Step 1: Discovery and Development.
- Step 2: Preclinical Research.
- Step 3: Clinical Research.
- Step 4: FDA Drug Review.
- Step 5: FDA Post-Market Drug Safety Monitoring.
...
FDA-Regulated Products and Facilities.
Program | Imports ($Billions) | Exports ($Billions) |
---|---|---|
Human and Animal Drugs | $93.62 | $31.67 |
Human Food and Cosmetics | $158.90 | $122.90 |
Medical Devices | $68.01 | $58.69 |
Tobacco | $1.58 | $1.05 |
A team of CDER physicians, statisticians, chemists, pharmacologists, and other scientists reviews the company's data and proposed labeling. If this independent and unbiased review establishes that a drug's health benefits outweigh its known risks, the drug is approved for sale.
FDA develops regulations based on the laws set forth in the Food, Drug, and Cosmetic Act (FD&C Act) or other laws – including the Family Smoking Prevention and Tobacco Control Act – under which FDA operates. FDA regulations have the full force of law.
What is FDA and their responsibility? ›Monitors, evaluates and ensures compliance of manufacturers, distributors, advertisers and retailers of processed foods, drugs and other related products to health rules and regulations and standards of quality.
First, FDA reviews the safety and effectiveness of new drugs that manufacturers2 wish to market in the United States; this process is called premarket approval or preapproval review. Second, once a drug has passed that threshold and is FDA-approved, FDA acts through its postmarket or postapproval regulatory procedures.
On August 23, 2021, FDA announced the first approval of a COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and the approved vaccine is marketed as Comirnaty, for the prevention of COVID-19 in individuals 12 years of age and older.
What are the different types of FDA approval? ›
To give patients earlier access to critical new drugs, four rapid FDA approval designations exist — priority review, breakthrough therapy, accelerated approval, and fast track.
To get FDA approval, drug manufacturers must conduct lab, animal, and human clinical testing and submit their data to FDA. FDA will then review the data and may approve the drug if the agency determines that the benefits of the drug outweigh the risks for the intended use.
How many drugs are FDA approved? ›There are over 19,000 prescription drug products approved for marketing.
FDA Drug-Approval Process. A pharmaceutical company seeking FDA approval to sell a new prescription drug must complete a five-step process: discovery/concept, preclinical research, clinical research, FDA review and FDA post-market safety monitoring.
How many types of drugs are there? ›DREs classify drugs in one of seven categories: central nervous system (CNS) depressants, CNS stimulants, hallucinogens, dissociative anesthetics, narcotic analgesics, inhalants, and cannabis.
Without FDA review, there is no way to know if these drugs are safe and effective for their intended use, whether they are manufactured in a way that ensures consistent drug quality or whether their label is complete and accurate.
How long FDA approval takes? ›The FDA approval process can take between one week and eight months, depending on whether you self-register, submit a 510(k) application, or submit a Premarket Approval (PMA) application. Bringing a medical device to market is not a fast process.
FDA regulates all foods and food ingredients introduced into or offered for sale in interstate commerce, with the exception of meat, poultry, and certain processed egg products regulated by the U.S. Department of Agriculture (USDA).
What is FDA final rule? ›The Final Rule states that the responsible party may authorize the National Institutes of Health (NIH) to publicly post clinical trial registration information for an applicable device clinical trial of a device product that has not been previously approved or cleared by the U.S. FDA.
FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices. FDA also has the responsibility in maintaining the safety of our nation's food supply (human and animal), cosmetics, and products that emit radiation.
Are FDA requirements law? ›
FDA regulations are also federal laws, but they are not part of the FD&C Act. FDA regulations can be found in Title 21 of the Code of Federal Regulations (CFR).
FDA is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medical products and foods to maintain and improve their health.”
What is the role of FDA in pharmaceutical industry? ›FDA Approval refers to the list of drugs approved by the Food and Drug Administration (FDA) for sale in the United States. New drugs receive extensive scrutiny before FDA approval in a process called a New Drug Application or NDA.
The agency regulates all foods and food ingredients introduced into or offered for sale in interstate commerce, except for meat, poultry, certain processed egg products, and catfish, which are regulated by the U.S. Department of Agriculture. The regulatory requirements may depend on the specific nature of your product.
Who created the FDA? ›Food and Drug Administration
FDA headquarters facilities are located in Montgomery and Prince Georges Counties in Maryland. Many FDA employees are consolidated at the White Oak Campus located in Silver Spring, MD. Remaining headquarters employees are housed in numerous additional buildings located across the Washington, D.C. area.
Why was the FDA created? ›The United States Food and Drug Administration (FDA) was first created to enforce the Pure Food and Drug Act of 1906. In this capacity, the FDA is charged with protecting the health of the US public, to ensure the quality of its food, medicine, and cosmetics.
The Janssen COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized by FDA through an Emergency Use Authorization (EUA) for active immunization to prevent Coronavirus Disease 2019 (COVID-19) in individuals 18 years of age and older.
Which vaccine is the safest? ›The Pfizer and Moderna vaccines are strongly recommended as safe and effective at preventing serious illness or death from COVID-19. From December 2020 to December 2021, about 470 million doses of COVID-19 vaccine have been given in the U.S.
Reinfection with the virus that causes COVID-19 means a person was infected, recovered, and then later became infected again. After recovering from COVID-19, most individuals will have some protection from repeat infections. However, reinfections do occur after COVID-19.
What is FDA classification? ›
The FDA generally classifies medical devices based on the risks associated with the device and by evaluating the amount of regulation that provides a reasonable assurance of the device's safety and effectiveness. Devices are classified into one of three regulatory classes: class I, class II, or class III.
Registration simply means the FDA is aware of the manufacturer and their devices. The manufacturer cannot claim the device is “FDA Cleared” or “Approved,” and they cannot use the FDA logo in marketing or labeling the device.
How do you verify FDA approval? ›- Drugs@FDA lists most prescription and over-the-counter (OTC) drug products approved since 1939. ...
- The FDA "Orange Book" contains drugs approved by FDA under New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs).
Overall success rates from Phase I to FDA approval is nearly 9%. This number is comprised of lead and secondary indications. When separated, lead indications have close to a one in seven rate of approval and secondary indications have a rate of one in 30.
What was the first FDA medication? ›1937. Elixir of Sulfanilamide, containing the poisonous solvent diethylene glycol, kills 107 persons, many of whom are children, dramatizing the need to establish drug safety before marketing and to enact the pending food and drug law.
Though FDA can trace its origins back to the creation of the Agricultural Division in the Patent Office in 1848, its origins as a federal consumer protection agency began with the passage of the 1906 Pure Food and Drugs Act.
How many FDA phases are there? ›There are three phases to complete in the clinical trial process before a sponsor can submit their treatments* to the FDA for consideration to be sold on the market. Each stage of a clinical trial has its own purpose in ensuring that a treatment is safe and effective for use by the public.
- depressants – slow down the function of the central nervous system.
- hallucinogens – affect your senses and change the way you see, hear, taste, smell or feel things.
- stimulants – speed up the function of the central nervous system.
- Depressants These are drugs that slow or depress the functions of the central nervous system and brain. ...
- Stimulants: Drugs that accelerate up the central nervous system are called stimulants. ...
- Opioids: Drugs that are used to suppress physical pain are called analgesics or opioids.
- Opioids.
- Stimulants.
- Depressants.
- Hallucinogens.
What is FDA and their responsibility? ›
Monitors, evaluates and ensures compliance of manufacturers, distributors, advertisers and retailers of processed foods, drugs and other related products to health rules and regulations and standards of quality.
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices.
What is the FDA and why was it created? ›The United States Food and Drug Administration (FDA) was first created to enforce the Pure Food and Drug Act of 1906. In this capacity, the FDA is charged with protecting the health of the US public, to ensure the quality of its food, medicine, and cosmetics.
The FDA: Protecting Consumers and Patients
The FDA is there to protect consumers and patients and ensure their safety by regulating and approving products, issuing recalls and safety notices, and alerting us to health scams and other health threats.
First, FDA reviews the safety and effectiveness of new drugs that manufacturers2 wish to market in the United States; this process is called premarket approval or preapproval review. Second, once a drug has passed that threshold and is FDA-approved, FDA acts through its postmarket or postapproval regulatory procedures.
Who leads the FDA? ›FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation's food supply, cosmetics, and products that emit radiation.
Does the FDA regulate food? ›The agency regulates all foods and food ingredients introduced into or offered for sale in interstate commerce, except for meat, poultry, certain processed egg products, and catfish, which are regulated by the U.S. Department of Agriculture. The regulatory requirements may depend on the specific nature of your product.
FDA Approval refers to the list of drugs approved by the Food and Drug Administration (FDA) for sale in the United States. New drugs receive extensive scrutiny before FDA approval in a process called a New Drug Application or NDA.
What drugs does the FDA regulate? ›
...
Biologics, including:
- vaccines for humans.
- blood and blood products.
- cellular and gene therapy products.
- tissue and tissue products.
- allergenics.
1937. Elixir of Sulfanilamide, containing the poisonous solvent diethylene glycol, kills 107 persons, many of whom are children, dramatizing the need to establish drug safety before marketing and to enact the pending food and drug law.
When did FDA approval begin? ›Although it was not known by its present name until 1930, FDA's modern regulatory functions began with the passage of the 1906 Pure Food and Drugs Act, a law a quarter-century in the making that prohibited interstate commerce in adulterated and misbranded food and drugs.